122 related articles for article (PubMed ID: 37734666)
21. Compassionate use of vismodegib and adjuvant radiotherapy in the treatment of multiple locally advanced and inoperable basal cell carcinomas and squamous cell carcinomas of the skin.
Gathings RM; Orscheln CS; Huang WW
J Am Acad Dermatol; 2014 Apr; 70(4):e88-e89. PubMed ID: 24629372
[No Abstract] [Full Text] [Related]
22. Anal Squamous Cell Carcinoma: Radiation Therapy Alone Must Be Avoided.
Almaazmi H; Taylor JP; Stem M; Yu D; Lo BD; Safar B; Efron JE
J Surg Res; 2020 Mar; 247():530-540. PubMed ID: 31648811
[TBL] [Abstract][Full Text] [Related]
23. Feasibility of endoscopic mucosal resection as salvage treatment for patients with local failure after definitive chemoradiotherapy for stage IB, II, and III esophageal squamous cell cancer.
Makazu M; Kato K; Takisawa H; Yoshinaga S; Oda I; Saito Y; Mayahara H; Ito Y; Itami J; Hamaguchi T; Yamada Y; Shimada Y
Dis Esophagus; 2014 Jan; 27(1):42-9. PubMed ID: 23442160
[TBL] [Abstract][Full Text] [Related]
24. Combined nimotuzumab with chemoradiotherapy in patients with locally advanced or metastatic esophageal squamous cell carcinoma: A retrospective study.
Lai X; Gu Q; Zheng X; Liu G; Feng W; Lin X; Mao W
J Cancer Res Ther; 2016 Oct; 12(Supplement):89-95. PubMed ID: 27721263
[TBL] [Abstract][Full Text] [Related]
25. Adjuvant radiation following clear margin resection of high T-stage cutaneous squamous cell carcinoma halves the risk of local and locoregional recurrence: A dual-center retrospective study.
Ruiz ES; Kus KJB; Smile TD; Murad F; Zhou G; Ilori EO; Schoenfeld JD; Margalit DN; Tishler RB; Vidimos AT; Koyfman SA; Schmults CD
J Am Acad Dermatol; 2022 Jul; 87(1):87-94. PubMed ID: 35364211
[TBL] [Abstract][Full Text] [Related]
26. Prospective study of definitive chemoradiation in locally or regionally advanced squamous cell carcinoma of the skin.
Nottage MK; Lin C; Hughes BG; Kenny L; Smith DD; Houston K; Francesconi A
Head Neck; 2017 Apr; 39(4):679-683. PubMed ID: 28032670
[TBL] [Abstract][Full Text] [Related]
27. Comparison of surgical complications after organ-preservation therapy in patients with stage III or IV squamous cell head and neck cancer.
Lavertu P; Bonafede JP; Adelstein DJ; Saxton JP; Strome M; Wanamaker JR; Eliachar I; Wood BG
Arch Otolaryngol Head Neck Surg; 1998 Apr; 124(4):401-6. PubMed ID: 9559686
[TBL] [Abstract][Full Text] [Related]
28. Value and application of trimodality therapy or definitive concurrent chemoradiotherapy in thoracic esophageal squamous cell carcinoma.
Lin WC; Ding YF; Hsu HL; Chang JH; Yuan KS; Wu ATH; Chow JM; Chang CL; Chen SU; Wu SY
Cancer; 2017 Oct; 123(20):3904-3915. PubMed ID: 28608916
[TBL] [Abstract][Full Text] [Related]
29. Concurrent Radiotherapy With Cetuximab or Platinum-based Chemotherapy for Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck.
Lu SM; Lien WW
Am J Clin Oncol; 2018 Jan; 41(1):95-99. PubMed ID: 26353121
[TBL] [Abstract][Full Text] [Related]
30. Nonrandomized comparison between definitive chemoradiotherapy and radical surgery in patients with T(2-3)N(any) M(0) squamous cell carcinoma of the esophagus.
Hironaka S; Ohtsu A; Boku N; Muto M; Nagashima F; Saito H; Yoshida S; Nishimura M; Haruno M; Ishikura S; Ogino T; Yamamoto S; Ochiai A
Int J Radiat Oncol Biol Phys; 2003 Oct; 57(2):425-33. PubMed ID: 12957254
[TBL] [Abstract][Full Text] [Related]
31. Adjuvant Chemotherapy Is Associated With Improved Survival for Late-Stage Salivary Squamous Cell Carcinoma.
Cheraghlou S; Schettino A; Zogg CK; Otremba MD; Bhatia A; Park HS; Osborn HA; Mehra S; Yarbrough WG; Judson BL
Laryngoscope; 2019 Apr; 129(4):883-889. PubMed ID: 30151947
[TBL] [Abstract][Full Text] [Related]
32. Management of the neck in metastatic cutaneous squamous cell carcinoma of the head and neck.
D'Souza J; Clark J
Curr Opin Otolaryngol Head Neck Surg; 2011 Apr; 19(2):99-105. PubMed ID: 21297477
[TBL] [Abstract][Full Text] [Related]
33. Effectiveness of incorporating cetuximab into docetaxel/cisplatin/fluorouracil induction chemotherapy and chemoradiotherapy for inoperable squamous cell carcinoma of the oral cavity: A phase II study.
Chang PM; Lu HJ; Wang LW; Tai SK; Chen MH; Chu PY; Yang MH
Head Neck; 2017 Jul; 39(7):1333-1342. PubMed ID: 28370774
[TBL] [Abstract][Full Text] [Related]
34. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
[TBL] [Abstract][Full Text] [Related]
35. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study.
Bradley JD; Paulus R; Komaki R; Masters G; Blumenschein G; Schild S; Bogart J; Hu C; Forster K; Magliocco A; Kavadi V; Garces YI; Narayan S; Iyengar P; Robinson C; Wynn RB; Koprowski C; Meng J; Beitler J; Gaur R; Curran W; Choy H
Lancet Oncol; 2015 Feb; 16(2):187-99. PubMed ID: 25601342
[TBL] [Abstract][Full Text] [Related]
36. A Population-Based Cohort Analysis of Chemoradiation Versus Radiation Alone for Definitive Treatment of Stage I Anal Cancer in Older Patients.
Buckstein M; Arens Y; Wisnivesky J; Gaisa M; Goldstone S; Sigel K
Dis Colon Rectum; 2018 Jul; 61(7):787-794. PubMed ID: 29771796
[TBL] [Abstract][Full Text] [Related]
37. Primary definitive radiotherapy with or without chemotherapy for squamous cell carcinoma of the temporal bone.
Kitani Y; Kubota A; Furukawa M; Sato K; Nakayama Y; Nonaka T; Mizoguchi N
Eur Arch Otorhinolaryngol; 2016 May; 273(5):1293-8. PubMed ID: 25822291
[TBL] [Abstract][Full Text] [Related]
38. Comparison of transthoracic esophagectomy with definitive chemoradiotherapy as initial treatment for patients with esophageal squamous cell carcinoma who could tolerate transthoracic esophagectomy.
Matsuda S; Tsubosa Y; Niihara M; Sato H; Takebayashi K; Kawamorita K; Mori K; Tsushima T; Yokota T; Ogawa H; Onozawa Y; Yasui H; Takeuchi H; Kitagawa Y
Ann Surg Oncol; 2015; 22(6):1866-73. PubMed ID: 25564176
[TBL] [Abstract][Full Text] [Related]
39. Weekly low-dose docetaxel-based chemoradiotherapy for locally advanced oropharyngeal or hypopharyngeal carcinoma: a retrospective, single-institution study.
Fukada J; Shigematsu N; Takeda A; Ohashi T; Tomita T; Shiotani A; Kunieda E; Kawaguchi O; Fujii M; Kubo A
Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):417-24. PubMed ID: 19409727
[TBL] [Abstract][Full Text] [Related]
40. Prognostic factors in definitive radiochemotherapy of advanced inoperable esophageal cancer.
Semrau R; Herzog SL; Vallböhmer D; Kocher M; Hölscher AH; Müller RP
Dis Esophagus; 2012 Aug; 25(6):545-54. PubMed ID: 22133297
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
